Concepts (44)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphangitis | 1 | 2021 | 3 | 0.180 |
Why?
|
| Carcinoma | 1 | 2021 | 74 | 0.170 |
Why?
|
| Sarcoidosis | 1 | 2020 | 38 | 0.160 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 153 | 0.160 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2020 | 60 | 0.160 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 57 | 0.160 |
Why?
|
| Monocytes | 1 | 2020 | 135 | 0.150 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 301 | 0.150 |
Why?
|
| Transcriptome | 1 | 2020 | 243 | 0.140 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 477 | 0.140 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 360 | 0.130 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2017 | 11 | 0.130 |
Why?
|
| Abdomen | 1 | 2017 | 41 | 0.130 |
Why?
|
| Intestinal Perforation | 1 | 2017 | 15 | 0.130 |
Why?
|
| Fatal Outcome | 2 | 2021 | 69 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 482 | 0.060 |
Why?
|
| Humans | 5 | 2022 | 29078 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2022 | 63 | 0.050 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2021 | 15 | 0.040 |
Why?
|
| Dyspnea | 1 | 2021 | 25 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 126 | 0.040 |
Why?
|
| Male | 3 | 2021 | 14049 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 191 | 0.040 |
Why?
|
| Oxygen | 1 | 2022 | 237 | 0.040 |
Why?
|
| Clonal Anergy | 1 | 2020 | 11 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2020 | 82 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2020 | 61 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 379 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2020 | 88 | 0.040 |
Why?
|
| Hospitalization | 1 | 2021 | 201 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 413 | 0.040 |
Why?
|
| Female | 3 | 2021 | 15740 | 0.040 |
Why?
|
| Cell Movement | 1 | 2020 | 377 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 481 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 740 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 415 | 0.040 |
Why?
|
| Models, Biological | 1 | 2020 | 471 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 787 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 781 | 0.030 |
Why?
|
| Shock, Septic | 1 | 2017 | 38 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2021 | 2430 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2020 | 1482 | 0.030 |
Why?
|
| Adult | 1 | 2021 | 8080 | 0.020 |
Why?
|
| Middle Aged | 1 | 2017 | 7458 | 0.010 |
Why?
|